Raja (Eladnani) Prince/LinkedIn
Dec 4, 2025, 02:34
Raja Prince and Team: Protein S as a Therapeutic Target
Raja Prince, Founder and BOD of BLEEDnFIRE Therapeutics, posted on LinkedIn:
”I’m delighted to share our newly published review in Journal of Thrombosis and Haemostasis (JTH).
In this article, our team provides an updated and comprehensive overview of protein S as a therapeutic target, summarizing current knowledge, emerging therapeutic strategies, and key challenges in the field of hemostasis.
A big thank you to my two coauthors, Rim Diab and Anne Angelillo-Scherrer.”
Read the full article here.
Title: Protein S as a therapeutic target
Authors: Raja Prince Eladnani, Rim Diab, Anne Angelillo-Scherrer
Stay updated with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 6, 2025, 06:34Akshat Jain: It was Wonderful Hosting and Meeting Industry Leaders on Their Visit Down to Southern California